A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer
Clinical trial NCT03048136 · WITHDRAWN
Trial details
- NCT number
- NCT03048136
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2019-09-29
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.